Neoadjuvant Complete Response Customized Treatment Approach for Definitive Management of Breast Cancer

Clinical trial NCT07217990 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07217990
Sponsor: Ohio State University Comprehensive Cancer Center
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Breast Cancer HER2-positive Breast Cancer Triple Negative Breast Cancer

Start date: 2026-09-15
Primary completion: 2027-12-31
Enrollment: 84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.